NEWS
Tags: 

Siena Biotech extends licence of AKS2

Siena Biotech has extended its license of Bioalma’s knowledge mining system, AKS2 (almaKnowledgeServer), distributed by Active Motif.

AKS2 provides a rapid way for researchers to explore information in published literature together with drug, symptom and biomedical results from Siena’s comprehensive proteomics platform.

‘The newly designed AKS2 will support our disease-based research,’ said Dr Georg C Terstappen, vice president of discovery research at Siena Biotech. ‘We have been working with Bioalma for some time now and the new AKS2 will help us extract knowledge from the data generated in our high-throughput experiments.’

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers